CHF Solutions, Inc, a medical device company, focuses on the provision of solutions for patients suffering from fluid overload. The company's commercial product is the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.
Read More…
Industry, Sector and Symbol
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Phone952-345-4200
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$5 million
Profitability
Miscellaneous
Employees55
Next Earnings Date11/5/2019 (Estimated)
OptionableNot Optionable
CHF Solutions (NASDAQ:CHFS) Frequently Asked Questions
What is CHF Solutions' stock symbol?
CHF Solutions trades on the NASDAQ under the ticker symbol "CHFS."
When did CHF Solutions' stock split? How did CHF Solutions' stock split work?
CHF Solutions shares reverse split on the morning of Friday, October 13th 2017. The 1-20 reverse split was announced on Thursday, October 12th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 12th 2017. An investor that had 100 shares of CHF Solutions stock prior to the reverse split would have 5 shares after the split.
How were CHF Solutions' earnings last quarter?
CHF Solutions Inc (NASDAQ:CHFS) posted its earnings results on Tuesday, August, 6th. The company reported ($1.93) EPS for the quarter, missing the consensus estimate of ($1.46) by $0.47. The business had revenue of $1.68 million for the quarter. CHF Solutions had a negative net margin of 306.81% and a negative return on equity of 193.21%. View CHF Solutions' Earnings History.
When is CHF Solutions' next earnings date?
Has CHF Solutions been receiving favorable news coverage?
News articles about CHFS stock have trended negative recently, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. CHF Solutions earned a news sentiment score of -2.9 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for CHF Solutions.
Are investors shorting CHF Solutions?
CHF Solutions saw a decrease in short interest during the month of August. As of August 15th, there was short interest totalling 48,500 shares, a decrease of 47.1% from the July 15th total of 91,700 shares. Based on an average daily trading volume, of 81,500 shares, the days-to-cover ratio is presently 0.6 days. Approximately 10.7% of the company's stock are sold short. View CHF Solutions' Current Options Chain.
Who are some of CHF Solutions' key competitors?
Some companies that are related to CHF Solutions include Precision Optics (PEYE), Digirad (DRAD), ENDRA Life Sciences (NDRA), Aradigm (ARDM), Non-Invasive Monitoring Systems (NIMU), Nexeon Medsystems (NXNN), Viveve Medical (VIVE), Vaso (VASO), Reshape Lifesciences (RSLS), Escalon Medical (ESMC), SpectraScience (SCIE), Trimedyne (TMED), Guided Therapeutics (GTHP), Magna-Lab (MAGAA) and Echo Therapeutics (ECTE).
What other stocks do shareholders of CHF Solutions own?
Who are CHF Solutions' key executives?
CHF Solutions' management team includes the folowing people:
- Mr. John L. Erb, Chairman, CEO & Pres (Age 70)
- Ms. Claudia Napal Drayton, Chief Financial Officer (Age 51)
- Mr. Vitaliy Epshteyn, Sr. VP of Operations & Engineering (Age 41)
- Mr. David Lerner, Sr. VP of Corp. Devel. & Technology
- Mr. Thomas P. Lynch, VP, Gen. Counsel, Chief Compliance Officer & Sec. (Age 52)
Who are CHF Solutions' major shareholders?
CHF Solutions' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Anson Funds Management LP (3.69%) and A.R.T. Advisors LLC (0.45%). Company insiders that own CHF Solutions stock include Gregory D Waller, John L Erb and Ki Yong Choi. View Institutional Ownership Trends for CHF Solutions.
Which major investors are buying CHF Solutions stock?
CHFS stock was acquired by a variety of institutional investors in the last quarter, including Anson Funds Management LP and A.R.T. Advisors LLC. Company insiders that have bought CHF Solutions stock in the last two years include John L Erb and Ki Yong Choi. View Insider Buying and Selling for CHF Solutions.
How do I buy shares of CHF Solutions?
Shares of CHFS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is CHF Solutions' stock price today?
One share of CHFS stock can currently be purchased for approximately $2.13.
How big of a company is CHF Solutions?
CHF Solutions has a market capitalization of $5.52 million and generates $5 million in revenue each year. The company earns $-17,030,000.00 in net income (profit) each year or ($42.14) on an earnings per share basis. CHF Solutions employs 55 workers across the globe.View Additional Information About CHF Solutions.
What is CHF Solutions' official website?
How can I contact CHF Solutions?
CHF Solutions' mailing address is 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN, 55344. The company can be reached via phone at 952-345-4200 or via email at [email protected]
MarketBeat Community Rating for CHF Solutions (NASDAQ CHFS)
MarketBeat's community ratings are surveys of what our community members think about CHF Solutions and other stocks. Vote "Outperform" if you believe CHFS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHFS will underperform the S&P 500 over the long term. You may vote once every thirty days.
